Scott R.  Bohn net worth and biography

Scott Bohn Biography and Net Worth

Scott Bohn has served as our Chief Development Officer and Head of Lab since 2024. In this role, he leads the Company’s leasing strategy for its life science portfolio and oversees the execution of strategic development initiatives across the portfolio.

Mr. Bohn joined Healthpeak in 2012 and has previously served as Director, Vice President, and Senior Vice President.

Before joining Healthpeak, Mr. Bohn held various development, acquisition, and leasing positions at Terreno Realty Corporation (NYSE: TRNO), AMB Property Corporation (now Prologis – NYSE: PLD), and RREEF/Deutsche Bank. Mr. Bohn received a Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign.

What is Scott R. Bohn's net worth?

The estimated net worth of Scott R. Bohn is at least $149.15 thousand as of May 12th, 2026. Bohn owns 7,636 shares of Healthpeak Properties stock worth more than $149,154 as of May 19th. This net worth approximation does not reflect any other investments that Bohn may own. Learn More about Scott R. Bohn's net worth.

How do I contact Scott R. Bohn?

The corporate mailing address for Bohn and other Healthpeak Properties executives is 309 N. WATER STREET SUITE 500, MILWAUKEE WI, 53202. Healthpeak Properties can also be reached via phone at (414) 367-5600 and via email at [email protected]. Learn More on Scott R. Bohn's contact information.

Has Scott R. Bohn been buying or selling shares of Healthpeak Properties?

During the past quarter, Scott R. Bohn has sold $213,736.05 in shares of Healthpeak Properties stock. Most recently, Scott R. Bohn sold 10,989 shares of the business's stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a transaction totalling $213,736.05. Following the completion of the sale, the insider now directly owns 7,636 shares of the company's stock, valued at $148,520.20. Learn More on Scott R. Bohn's trading history.

Who are Healthpeak Properties' active insiders?

Healthpeak Properties' insider roster includes Laurie Becker (SVP), Albert Black, Jr. (Director), Scott Bohn (Insider), Scott Brinker (President and Chief Executive Officer), Daniel Klein (SVP), Bradley Page (SVP), Pamela Shelley-Kessler (Director), Jeffrey Theiler (CFO), John Thomas (President & CEO), and Tommy Thompson (Director). Learn More on Healthpeak Properties' active insiders.

Are insiders buying or selling shares of Healthpeak Properties?

During the last year, Healthpeak Properties insiders bought shares 5 times. They purchased a total of 14,560 shares worth more than $249,898.19. During the last year, insiders at the real estate investment trust sold shares 1 times. They sold a total of 10,989 shares worth more than $213,736.05. The most recent insider tranaction occured on May, 12th when insider Scott R Bohn sold 10,989 shares worth more than $213,736.05. Insiders at Healthpeak Properties own 0.2% of the company. Learn More about insider trades at Healthpeak Properties.

Information on this page was last updated on 5/12/2026.

Scott R. Bohn Insider Trading History at Healthpeak Properties

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2026Sell10,989$19.45$213,736.057,636View SEC Filing Icon  
See Full Table

Scott R. Bohn Buying and Selling Activity at Healthpeak Properties

This chart shows Scott R Bohn's buying and selling at Healthpeak Properties by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Healthpeak Properties Company Overview

Healthpeak Properties logo
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Today's Range

Now: $19.31
Low: $19.58
High: $19.58

50 Day Range

MA: $17.31
Low: $15.99
High: $19.77

2 Week Range

Now: $19.31
Low: $15.70
High: $19.91

Volume

878 shs

Average Volume

9,114,595 shs

Market Capitalization

$13.31 billion

P/E Ratio

60.28

Dividend Yield

6.24%

Beta

1